长江商报消息 ●长江商报记者 沈右荣 中国医药外包（CXO）行业的头部企业?康龙化成（300759.SZ，03759.HK）筹划的收购，引发市场质 疑。 根据此前公告，康龙化成拟出资13.46亿元收购无锡佰翱得生物科学股份有限公司（以下简称"佰翱 得"或"标的公司"）82.54%的股份。 此次收购，康龙化成践行"全流程、一体化、国际化、多疗法"的核心战略，强化技术平台建设。 康龙化成主营提供药物研究、开发与生产及临床全流程的一体化服务，在业内具有一定的市场地位。 康龙化成的本次收购，引发市场关注的是关联交易。如果本次交易完成，公司关联方将套现约5亿元。 本次收购采用现金支付，而康龙化成财务承压。截至2025年9月末，公司有息负债约60亿元，前三季度 财务费用1.53亿元。 2025年前三季度，康龙化成实现营业收入100.86亿元，创新高，但归母净利润同比下降19.76%。 二级市场上，11月24日，康龙化成的收盘价为29元/股，较2021年8月5日的巅峰下跌了逾70%。 财务承压仍现金收购 康龙化成的现金收购资产公告，惹来争议。 近期，康龙化成公告称，为践行公司的"全流程、一体化、国际化、多疗法"的核心战略， ...

Core Viewpoint - The report reveals a fatal accident at Kanglong Chemical (康龙化成), where two employees died due to asphyxiation caused by nitrogen gas in a flexible isolator during a night shift on June 3, 2023. The company failed to disclose this incident in a timely manner, citing it did not meet disclosure standards [4][5][6]. Group 1: Accident Details - The accident occurred in the purification room of Kanglong Chemical's facility in Beijing Economic-Technological Development Area [4]. - The two deceased employees had 6 and 8 years of experience, respectively, and were performing routine tasks when the incident happened [4][5]. - The direct cause of death was identified as a significant drop in oxygen levels due to nitrogen gas being introduced into the flexible isolator without proper safety measures [5][6]. Group 2: Investigation Findings - The investigation concluded that the accident was a result of non-compliance with safety protocols, specifically the failure to use gloves while operating within the flexible isolator [6]. - Indirect causes included inadequate enforcement of safety regulations and insufficient safety training for the employees involved [6]. - The investigation team recommended penalties for 10 management personnel at Kanglong Chemical, including fines based on their annual salaries [6]. Group 3: Company Performance - In the first half of 2025, Kanglong Chemical reported revenue of 6.441 billion yuan, a year-on-year increase of 14.93% [7]. - The net profit attributable to shareholders decreased by 37% to 701 million yuan, while the net profit excluding non-recurring items increased by 36.66% to 637 million yuan [7].